cimb-logo

Journal Browser

Journal Browser

Molecular Diagnostics, Pathology and Biomarkers of Neurodevelopmental Disorders

A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 6161

Special Issue Editor


E-Mail Website
Guest Editor
Department of Neurology, Laboratory of Neuroimmunology, Medical University of Lodz, 90-153 Lodz, Poland
Interests: neuroinflammation; neurodegeneration; demyelinating diseases of the CNS; multiple sclerosis; NMOSD; MOGAD; sex hormones; testosterone

Special Issue Information

Dear Colleagues,

The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition: DSM-5 defines neurodevelopmental disorders as “a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning”. NDDs are a heterogeneous group of disorders that are rather difficult to characterize because they present with diverse symptoms. They are very widespread, severely hampering the life of those affected and their families and the entire society as a whole. Despite the increasing focus in this field, mechanisms responsible for abnormal brain function in NDDs are still not fully understood, necessitating further research to improve the quality of life of  individuals with NDDs.

This Special Issue will include following topics:

  • Genetic regulation of expansion of neocortex;
  • The role of radial glia signaling in development of NDDs;
  • The role of neuroinflammation, particularly microglia signaling in development of NNDs;
  • Molecular mechanisms of sexual dimorphism in NDDs;
  • Molecular biomarkers of NDDs;
  • Experimental models of NDDs;
  • Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) differentiation into neuronal line as 2D in vitro models of neurodevelopmental disorders;
  • Use of brain organoids (stem cell-derived self-organized 3D tissues) that mimic the cytoarchitecture, cellular composition as well as gene expression of the fetal human brain as D model of NDDs;
  • Rodent models of NDDs.

Dr. Bartosz Bielecki
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • radial glia
  • neuronal progenitors
  • microglia
  • neuroinflammation

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 2931 KiB  
Article
Amelioration of Motor Performance and Nigrostriatal Dopamine Cell Volume Using a Novel Far-Infrared Ceramic Blanket in an A53T Alpha-Synuclein Transgenic Parkinson’s Disease Mouse Model
by Frederick Robert Carrick, Luis Sebastian Alexis Valerio Hernandez and Kiminobu Sugaya
Curr. Issues Mol. Biol. 2023, 45(12), 9823-9837; https://doi.org/10.3390/cimb45120613 - 6 Dec 2023
Viewed by 5973
Abstract
We had attended a Parkinson’s Disease (PD) patient for a non-healing wound who reported a marked decrease in his hand tremor and freezing of gait when his wound was exposed to a ceramic far-field infrared (cFIR) blanket. PD is the most frequent motor [...] Read more.
We had attended a Parkinson’s Disease (PD) patient for a non-healing wound who reported a marked decrease in his hand tremor and freezing of gait when his wound was exposed to a ceramic far-field infrared (cFIR) blanket. PD is the most frequent motor disorder and the second most frequent neurodegenerative disease after Alzheimer’s Disease (AD). The tremor, rigidity, and slowness of movement associated with Parkinson’s disease (PD) affect up to 10 million people throughout the world, and the major contributing factor to the pathogenesis of PD is the accumulation and propagation of pathological α-synuclein (α-Syn) and the death of dopaminergic cells in the Nigrostriatal system. Efforts to slow or stop its spreading have resulted in the development and use of dopaminergic drug replacement therapy. Unfortunately, there is a loss of about 70–80% of substantia nigral dopaminergic neurons in patients by the time they are diagnosed with PD, and various dopaminergic drugs provide only temporary relief of their motor symptoms. There are limitations in treating PD with many conventional medications, necessitating a combination of pharmaceutical and non-pharmacological therapy as an essential adjunct to better address the health and welfare of PD patients. We used male adult A53T alpha-synuclein transgenic mice exposed to a ceramic far-infrared blanket. Motor activity was assessed using the rotarod apparatus, and mouse brains were examined to quantify the fluorescence intensities of the immunostained samples. A53T alpha-synuclein transgenic mice had a significantly shorter time stay on the rotating bar than the wild-type mice (B6C3H). The rotarod performance was significantly improved in A53T alpha-synuclein transgenic mice exposed to cFIR as well as B6C3H healthy wild mice exposed to cFIR. There was a significant statistical and substantive increase in the cellular composition of the Striatum and substantia nigra of cFIR-treated mice. Improvement in motor performance is seen in PD mice and wild mice and is associated with increases in cell volume in the substantia nigra and striatum after treatment. Full article
Show Figures

Figure 1

Back to TopTop